• Open Account

Mercury Laboratories Ltd

Small Cap | Pharmaceuticals
₹
Last updated: 09-Aug-2026 ,

Mercury Laboratories Ltd Live Price Chart

Performance

Low: ₹0 High: 0
Previous Close ₹
High ₹
Volume
52W Range ₹ - ₹
Open ₹
Low ₹
Market Cap ₹ 100.2 Cr

Mercury Laboratories Ltd Technicals

Current Price
₹ No value
EMASMA
20 Day ₹ 808.143
50 Day ₹ 802.449
100 Day ₹ 800.146
200 Day ₹ 813.685
20 Day ₹ 815.957
50 Day ₹ 800.355
100 Day ₹ 690.758
200 Day ₹ 705.274

Mercury Laboratories Ltd Fundamentals

ROCE 10.754
P/E Ratio 23.600
P/B Ratio 1.690
Industry P/E 1.690
Debt to Equity 50.676
ROE 8.324
EPS 34.700
Dividend Yield 0.430
Book Value 484.000
Face Value 10.000

Mercury Laboratories Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 76.1699 76.6475 77.053 58.7397 69.4817
Total Expenses 71.5082 69.7272 69.6084 53.8328 61.5727
Profit After Tax 3.1449 5.6542 5.5788 3.5619 5.3375

Mercury Laboratories Ltd Shareholding Pattern

Promoter Holdings 73.658 %
FIIs 0.000 %
DIIs 0.000 %
MutualFund 0.000 %
Retail 16.578 %
Others - 9.764 %

About Mercury Laboratories Ltd

Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962. Subsequently, it converted into Private Limited Company & incorporated in February, 1982. Later, it converted into Limited Company in 1992 in Maharashtra. The Company has obtained ISO 9001:2008 registrations. It is engaged into the manufacturing and export of wide range of Pharmaceutical items. The Company products have been in Gynae and Pediatrics Segment. It is mainly dedicated to Mother & Child Healthcare. Two new products launched in Ergacap Division in 2012-13. The Company introduced new drugs such as Teclobet, Tanolite, Clinzit, Clinzita-A, Levotryl Tablet, Levotryl-M Tablet, Levotryl Syrup, THA-4, THA-8, Pyloryl, Pangs At, Feveryl Drops, Feveryl Suspension in its Mother Child Care specialized segment. It further established Institutional Business with Govt. Institutions, Semi Government and Hospitals & Clinics in 2014-15. The Company launched new world class GMP facility for all its liquids and tablets conforming requirement of WHO in 2015-16. It also has increased the manufacturing capacity for tablets and liquids in 2023-24. ...

FAQs on Mercury Laboratories Ltd

1. Can I buy Mercury Laboratories Ltd from PL Capital? ›

Yes, you can invest in Mercury Laboratories Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Mercury Laboratories Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Mercury Laboratories Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Mercury Laboratories Ltd pay dividends? ›

Yes, Mercury Laboratories Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Mercury Laboratories Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Mercury Laboratories Ltd ? ›

As of 09-Aug-2026 , the share price for Mercury Laboratories Ltd. is ₹ on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Mercury Laboratories Ltd ? ›

The 52-week high and low of Mercury Laboratories Ltd share price is ₹ - ₹ as of 09-Aug-2026 , .
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP

Start SIP in Mercury Laboratories Ltd

Invest systematically in stocks with the
PL Capital app

Get the App
Start SIP mobile app preview
App QR Code

Download the PL Capital App

Open Demat Account
×
I consent to receive calls/messages from PL